On September 18, 2024, the SFARI Autism Rat Consortium (ARC) held its annual meeting in the Usher Institute of the University of Edinburgh. This year’s event brought together ARC PIs and trainees who specialize in the use of rat models.

On January 25–26, 2024, SFARI welcomed researchers to a workshop to discuss SFARI Gene and other existing databases and other tools focused on different aspects of autism genetics, as well as databases curating autism-relevant datasets that are broader in scope. Speakers highlighted the roles of their resources, how they are curated and maintained, and how they integrate with SFARI Gene or other resources or might do so in the future.

On January 8–9, 2024, SFARI welcomed researchers to its second annual meeting of the SFARI Sex Differences Collaboration (SSDC).

On January 30–31, SFARI convened its first annual meeting of the SFARI Sex Differences Collaboration (SSDC). Funded in 2021, the SSDC collaboration consists of five groups of researchers who seek to understand the male overrepresentation in autism spectrum disorder (ASD) diagnoses; how this comes about could hold important insights into the nature of autism itself.

On February 10, 2023, SFARI hosted an in-person meeting focused on measuring sensory system function in humans with autism spectrum disorder (ASD) and other neurodevelopmental disorders (NDD).

On August 4, 2022, SFARI and Simons Searchlight helped to host two scientific workshops focused on neurodevelopmental disorders (NDDs) that are linked to mutations in the CSNK2A1 and SETBP1 genes. Meeting in Baltimore, the workshops were held in conjunction with a family conference that gathered together people with these conditions and their family members.

SFARI hosted a virtual workshop on March 14 and 18, 2022, to discuss the best practices for the development and use of induced pluripotent stem (iPS) cell models for autism research, including iPS cells generated from SFARI autism cohorts.

On March 25 and 28, 2022 SFARI hosted a workshop to explore the role of mitochondria in ASD risk. The workshop brought together experts in mitochondrial research spanning cellular, molecular, genetic, clinical and pharmacological areas and provided points for discussion on how to move this research forward.

A joint project of the Foundation for Angelman Syndrome Therapeutics (FAST) and SFARI, the International Angelman Syndrome Research Council (INSYNC-AS) held its inaugural meeting on July 9, 2021.

On September 27, 2021, SFARI convened a one-day virtual workshop to explore and discuss opportunities and risks for early detection of neurodevelopmental disorders through genomic sequencing.